As UBE2Z (UBA6‐specific E2s) was significantly co‐upregulated in both squamocin‐treated HNSCC cell lines (Figure 6B), we next investigated whether UBE2Z could mediate the degradation of both EZH2 and MYC. Here, UBA6 is linked to head and neck squamous cell carcinoma.